Advisory Board
The Advisory Board of the Department of Bioengineering consists of a select group of industrial leaders and academic representatives who are primarily alumni of the department or members of its constituent groups. They have shown leadership and professional success in their career and are fully dedicated to helping Clemson University develop and maintain highly competitive research and educational programs in bioengineering.
Members of the Advisory Board partner with the Chair of the Department of Bioengineering and are appointed for a three-year term. Following a term, members can be reappointed annually at the discretion of the Chair. A maximum of 15 members will serve on the Board at any given time. Membership representation shall reflect the bioengineering profession.
Current Members
Stephen Ainsworth*
Executive Vice President of Strategy & Technology, ChoiceSpine
Andrew Cobb*
Medtronic
Rebecca DeLegge*, (Chair)
CEO and Founder, DeLegge Medical
John Gilpin
Diagnostic Radiology, Prisma Health
Andrew Green*
EVP and General Manager of Cardiovascular Products at Aziyo Biologics, Inc.
Harry Thomas Hall I.V.*
Global Orthopaedic Franchise Leader, Trauma, Craniomaxillofacial, and Veterinary for Depuy Synthes
Steve Johnson
Investment Manager, SCRA
Marc Long*
VP Research and Development, Musculoskeletal Transplant Foundation
Joshua Lovekamp*
Business Unit Leader, W.L. Gore & Associates, Inc.
David Shalaby
President, Poly-Med, Inc.
Scott Taylor
Chief Technology Officer, Poly-Med Inc.
Jennifer Woodell-May*
Program Director, Advanced Osteoarthritis Therapies, Zimmer Biomet
* Clemson Bioengineering Alumnus
